Ignite Creation Date:
2025-12-24 @ 8:02 PM
Ignite Modification Date:
2026-01-22 @ 4:23 AM
Study NCT ID:
NCT03676504
Status:
RECRUITING
Last Update Posted:
2024-07-29
First Post:
2018-09-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR
Sponsor:
University Hospital Heidelberg
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-07
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2018-09-07
First Submit QC Date:
None
Study First Post Date:
2018-09-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-26
Last Update Post Date:
2024-07-29
Last Update Post Date Type:
ACTUAL